Gamma-aminobutyric acid type A receptor alpha3beta2gamma2 subtype (GABA_A receptor α3βγ2)

The GABA_A receptor α3βγ2 subtype is a pentameric ligand-gated ion channel that functions as a major mediator of fast inhibitory neurotransmission in the mammalian central nervous system [1, 11]. It is typically composed of two α3 subunits, two β subunits (most commonly β2 or β3), and one γ2 subunit, which together form a pore selective for chloride and bicarbonate ions [3, 5]. Upon activation by the neurotransmitter gamma-aminobutyric acid (GABA), the channel opens to hyperpolarize the postsynaptic membrane, thereby reducing neuronal excitability [11, 16]. This specific subtype is highly expressed in brain regions such as the thalamus, amygdala, and monoaminergic nuclei, where it regulates emotional states and sensory processing [7, 8]. Pharmacologically, α3-containing receptors are key targets for benzodiazepines and novel subtype-selective positive allosteric modulators (PAMs) like darigabat [2, 6]. These drugs are designed to provide anxiolytic, anticonvulsant, and myorelaxant effects while avoiding the heavy sedation and ataxia typically mediated by α1-containing GABA_A receptors [4, 6]. Consequently, the α3βγ2 subtype is a primary focus for developing safer treatments for generalized anxiety disorder, epilepsy, and chronic pain [2, 12].

Other names

GABA(A) receptor alpha3beta2gamma2GABRA3/GABRB2/GABRG2 complexalpha3-containing GABA_A receptorGABA-A receptor; alpha-3/beta-2/gamma-2

Positive allosteric modulation at the benzodiazepine binding site (alpha/gamma interface) to enhance GABA-induced chloride conductance.